Editorial
doi: 10.1016/j.jacc.2017.01.044.
Should Nonischemic CRT Candidates Receive CRT-P or CRT-D?
Affiliations
- PMID: 28359512
- DOI: 10.1016/j.jacc.2017.01.044
Item in Clipboard
Editorial
Should Nonischemic CRT Candidates Receive CRT-P or CRT-D?
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: cardiomyopathies; heart failure; implantable defibrillators; sudden cardiac death.
Comment on
-
Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.J Am Coll Cardiol. 2017 Apr 4;69(13):1669-1678. doi: 10.1016/j.jacc.2017.01.042. J Am Coll Cardiol. 2017. PMID: 28359511
Similar articles
-
Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.Europace. 2015 Dec;17(12):1816-22. doi: 10.1093/europace/euv201. Epub 2015 Jun 11. Europace. 2015. PMID: 26071234 Clinical Trial.
-
The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).J Am Coll Cardiol. 2014 Apr 1;63(12):1190-1197. doi: 10.1016/j.jacc.2013.10.074. Epub 2013 Dec 11. J Am Coll Cardiol. 2014. PMID: 24333490 Clinical Trial.
-
Patients upgraded to cardiac resynchronization therapy due to pacing-induced cardiomyopathy are at low risk of life-threatening ventricular arrhythmias: a long-term cause-of-death analysis.Europace. 2018 Jan 1;20(1):89-96. doi: 10.1093/europace/euw321. Europace. 2018. PMID: 28031276
-
Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis.Europace. 2018 Mar 1;20(3):481-491. doi: 10.1093/europace/eux094. Europace. 2018. PMID: 28666319
-
Long-term efficacy of implantable cardiac resynchronization therapy plus defibrillator for primary prevention of sudden cardiac death in patients with mild heart failure: an updated meta-analysis.Heart Fail Rev. 2016 Jul;21(4):447-53. doi: 10.1007/s10741-016-9550-y. Heart Fail Rev. 2016. PMID: 27043219 Review.
Cited by
-
Is there a benefit of ICD treatment in patients with persistent severely reduced systolic left ventricular function after TAVI?Clin Res Cardiol. 2022 May;111(5):492-501. doi: 10.1007/s00392-021-01826-x. Epub 2021 Mar 23. Clin Res Cardiol. 2022. PMID: 33758967 Free PMC article.
-
Mapping the research trends and hot topics of ventricular arrhythmia: A bibliometric analysis from 2001 to 2020.Front Cardiovasc Med. 2022 Oct 20;9:856695. doi: 10.3389/fcvm.2022.856695. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36337873 Free PMC article.
-
Time to Shock the System: Moving Beyond the Current Paradigm for Primary Prevention Implantable Cardioverter-Defibrillator Use.J Am Heart Assoc. 2020 Mar 3;9(5):e015139. doi: 10.1161/JAHA.119.015139. Epub 2020 Feb 24. J Am Heart Assoc. 2020. PMID: 32089058 Free PMC article. Review. No abstract available.
-
The Role of ARNI in Enhancing Outcomes of Cardiac Resynchronization Therapy: A Comprehensive Review.J Clin Med. 2025 Apr 16;14(8):2743. doi: 10.3390/jcm14082743. J Clin Med. 2025. PMID: 40283572 Free PMC article. Review.
-
Will introduction of ARNI reduce the need of device therapy in heart failure with reduced ejection fraction?Egypt Heart J. 2021 Mar 16;73(1):26. doi: 10.1186/s43044-021-00152-x. Egypt Heart J. 2021. PMID: 33725186 Free PMC article. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
